Concepedia

Katya Mokretar

KM

Statistics

Publications

3

Citations

142

H-Index

3

Active since

2023

Affiliations

Guy's and St Thomas' NHS Foundation Trust(Current)

The University of Sydney

University Hospital Southampton NHS Foundation Trust

Leeds Teaching Hospitals NHS Trust

King's College London

Katya Mokretar is an author at Guy's and St Thomas' NHS Foundation Trust specializing in negativity, oncology, and hematologic malignancy therapy.

Publications per year

2023–2023

3

Publications

3

Molecular MRD is strongly prognostic in patients with <i>NPM1</i>-mutated AML receiving venetoclax-based nonintensive therapy

Jad Othman, Ing Soo Tiong, Jenny O’Nions et al. · Blood · 2023 · 65 citations · Full text

, , +14

FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML

Jad Othman, Nicola Potter, Katya Mokretar et al. · Leukemia · 2023 · 48 citations · Full text

, , +13

Venetoclax–based low intensity therapy in molecular failure of <i>NPM1</i>-mutated AML

Carlos Jiménez‐Chillón, Jad Othman, David Taussig et al. · Blood Advances · 2023 · 29 citations · Full text

, , +13

1–3 of 3